Pricing Log in Create free account

COSCIENS Biopharma Inc. (CSCIF) vs MetaVia Inc. (MTVA)

COSCIENS Biopharma Inc. and MetaVia Inc. are both Biotechnology companies. COSCIENS Biopharma Inc. and MetaVia Inc. are of similar size ($9.0M and $8.6M). MetaVia Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs 0.00%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 12 metrics below, COSCIENS Biopharma Inc. leads on 7 and MetaVia Inc. on 5.

Valuation

Metric CSCIF MTVA Biotechnology median
P/E 1.03 n/m 8.50
P/S 0.78 n/m 9.71
P/B 0.46 1.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.09 0.64
EV/Sales 0.17 n/m 9.21
Earnings yield 96.93% (178.24%) (33.15%)
Free cash flow yield (45.48%) (211.89%) (25.50%)

Profitability

Metric CSCIF MTVA Biotechnology median
Gross margin 46.48% — 65.16%
Operating margin (71.13%) 0.00% 0.00%
Net margin 75.11% 0.00% 0.00%
Free cash flow margin (40.36%) 0.00% 0.00%
Return on equity 59.74% (175.68%) (56.36%)
Return on assets 28.24% (91.06%) (48.04%)
Return on invested capital (40.56%) 0.00% 0.00%

Growth

Metric CSCIF MTVA Biotechnology median
Revenue growth (TTM) (3.02%) — 6.02%
EPS growth (last fiscal year) 44.86% 81.23% 30.26%
Revenue growth, 5-year CAGR 15.47% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSCIF MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.33 2.06 4.72
Net debt to EBITDA 0.78 0.75 0.96

Dividend

Metric CSCIF MTVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSCIF MTVA Biotechnology median
Market cap 8.57m 9.03m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack